Abstract. The crystal structures of two pairs of diastereomeric salts consisting of ephedrine and a cyclic phosphoric acid were analyzed in detail.. One pair (R = H; Figure 1) shows no difference in solubility, as reflected in identical non-bonded interaction patterns in the two salts. The other pair (R = C1; Figure 1) shows a significant solubility difference; the crystal packings of these two salts differ considerably. The less soluble salt shows far more favorable Van der Waals interactions, presenting further evidence that the result of optical resolutions by selective crystallization are determined by these weak interactions. This study, in combination with the results presented in the previous paper (Towards a rational design of resolving agents, Part 11), suggests that a model might be developed describing a (quantitative) relationship between the lattice energy difference in a diastereomeric pair and the resolution efficiency of the resolving agent.
Abstract. The effects of various aromatic substituents in both ephedrine and a cyclic phosphoric acid on the quality of resolution via diastereomeric salt formation are investigated. The diastereoselective synthesis of a novel series of chloro-substituted ephedrines is described. These chloroephedrines can be resolved efficiently with some of the cyclic phosphoric acids. By studying the physical properties of nineteen pairs of diastereomeric salts, we show that the quality o f the resolution depends mainly on the aromatic substituent o f the cyclic phosphoric acid, whereas substituents at the phenyl ring of ephedrine play a secondary role.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.